Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

0(0%)

Results Posted

25%(1 trials)

Phase Distribution

Ph phase_2

20%

Ph phase_4

80%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 2Efficacy & side effects

1(20.0%)

Phase 4Post-market surveillance

4(80.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Other(1)

Detailed Status

Completed4

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 21 (20.0%)

Phase 44 (80.0%)

Trials by Status

completed480%

unknown120%

Recent Activity

0 active trials

Showing 5 of 5

completedphase_2

Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults

NCT01967368

completedphase_4

Study to Compare Self-administered and Nurse-administered Intradermal Influenza Vaccine

NCT01224613

Clinical Trials (5)

Showing 5 of 5 trials

NCT02960815Phase 2

Imiquimod and Influenza Vaccine for Immunocompromised Patients

Completed

NCT01665807Phase 4

A Time-motion Study Comparing Self- to Nurse-vaccination With Influenza Vaccine

Completed

NCT01368796Phase 4

Comparison of 4 Influenza Vaccines in Seniors

Completed

NCT01967368Phase 4

Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults

Unknown

NCT01224613Phase 4

Study to Compare Self-administered and Nurse-administered Intradermal Influenza Vaccine

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5